We show that AurA and Plk1, both involved in centrosome maturation and bipolar spindle assembly can be targeted to kill GSCs more effectively, and propose that this strategy might improve outcomes for patients with glioblastoma. The gene discussed is AURKA; the disease is glioblastoma.